not sure who the companies (Merck) are but the old strategy of anteobind only being used for eugeni have been shelved.
- Meaningful discussions with parties involved in the point of care development relating to a joint point-of-care (POC) assay development and validation work for the incorporation of AnteoBind were commenced.
- Development of assay and conjugation services offering, using AnteoBind activated particles was offered to commercial partners.
not sure who the companies (Merck ;)) are but the old strategy...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.98M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.2¢ | $16.78K | 762.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 3542852 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1207313 | 3 |
View Market Depth
| Last trade - 13.18pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
0.000 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 528427 | ||
| Last updated 12.40pm 30/04/2024 ? | |||||
| ADO (ASX) Chart |